RxDoctor Payments Data

Angela Freeman, DPM

Podiatrist · Binghamton, NYNPI 1275976128

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (55.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Prodigy Surgical Distribution, Inc. at 42.5% of the total. Reporting peaked in 2020 at $3,595 and has fallen 89.3% since, to $384 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,531in general payments, 2019–2025

Across 174 payments — averaging $83.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prodigy Surgical Distribution, Inc.$6K
  • Arthrex$3K
  • Smith+Nephew$2K
  • Smoky Mountain Surgical LLC$1K
  • Paratek Pharmaceuticals, Inc.$516
  • Organogenesis Inc.$353
  • plus $2K from 18 others

What the payments were for

  • Travel & lodging$2,67618%
  • Food & beverage$3,81226%
  • Education$8,04455%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,531 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$407,931
Medicare patients
585
Services billed
5,731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole77$1,592
Gabapentin95$1,568
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip39$1,182
Lidocaine12$1,039
Doxycycline Hyclate34$597
Cephalexin54$457
Colchicine12$385
Ammonium Lactate11$322
Methylprednisolone25$298
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$226
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$197
Mupirocin12$178
Meloxicam75$168
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$122
Levofloxacin17$117

Paid to pharmacies, not to this prescriber.

Other podiatrist in Binghamton

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →